Cargando…

Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy

MicroRNAs (miRNAs) are small non-coding RNAs with a known role as mediators of gene expression in crucial biological processes, which converts them into high potential contenders in the ongoing search for effective therapeutic strategies. However, extracellular RNAs are unstable and rapidly degraded...

Descripción completa

Detalles Bibliográficos
Autores principales: del Pozo-Acebo, Lorena, López de las Hazas, M-C, Tomé-Carneiro, Joao, Gil-Cabrerizo, Paula, San-Cristobal, Rodrigo, Busto, Rebeca, García-Ruiz, Almudena, Dávalos, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865385/
https://www.ncbi.nlm.nih.gov/pubmed/33499350
http://dx.doi.org/10.3390/ijms22031105
_version_ 1783647833773047808
author del Pozo-Acebo, Lorena
López de las Hazas, M-C
Tomé-Carneiro, Joao
Gil-Cabrerizo, Paula
San-Cristobal, Rodrigo
Busto, Rebeca
García-Ruiz, Almudena
Dávalos, Alberto
author_facet del Pozo-Acebo, Lorena
López de las Hazas, M-C
Tomé-Carneiro, Joao
Gil-Cabrerizo, Paula
San-Cristobal, Rodrigo
Busto, Rebeca
García-Ruiz, Almudena
Dávalos, Alberto
author_sort del Pozo-Acebo, Lorena
collection PubMed
description MicroRNAs (miRNAs) are small non-coding RNAs with a known role as mediators of gene expression in crucial biological processes, which converts them into high potential contenders in the ongoing search for effective therapeutic strategies. However, extracellular RNAs are unstable and rapidly degraded, reducing the possibility of successfully exerting a biological function in distant target cells. Strategies aimed at enhancing the therapeutic potential of miRNAs include the development of efficient, tissue-specific and nonimmunogenic delivery methods. Since miRNAs were discovered to be naturally transported within exosomes, a type of extracellular vesicle that confers protection against RNase degradation and increases miRNA stability have been proposed as ideal delivery vehicles for miRNA-based therapy. Although research in this field has grown rapidly in the last few years, a standard, reproducible and cost-effective protocol for exosome isolation and extracellular RNA delivery is lacking. We aimed to evaluate the use of milk-derived extracellular vesicles as vehicles for extracellular RNA drug delivery. With this purpose, exosomes were isolated from raw bovine milk, combining ultracentrifugation and size exclusion chromatography (SEC) methodology. Isolated exosomes were then loaded with exogenous hsa-miR148a-3p, a highly expressed miRNA in milk exosomes. The suitability of exosomes as delivery vehicles for extracellular RNAs was tested by evaluating the absorption of miR-148a-3p in hepatic (HepG2) and intestinal (Caco-2) cell lines. The potential exertion of a biological effect by miR-148a-3p was assessed by gene expression analysis, using microarrays. Results support that bovine milk is a cost-effective source of exosomes which can be used as nanocarriers of functional miRNAs with a potential use in RNA-based therapy. In addition, we show here that a combination of ultracentrifugation and SEC technics improve exosome enrichment, purity, and integrity for subsequent use.
format Online
Article
Text
id pubmed-7865385
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78653852021-02-07 Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy del Pozo-Acebo, Lorena López de las Hazas, M-C Tomé-Carneiro, Joao Gil-Cabrerizo, Paula San-Cristobal, Rodrigo Busto, Rebeca García-Ruiz, Almudena Dávalos, Alberto Int J Mol Sci Article MicroRNAs (miRNAs) are small non-coding RNAs with a known role as mediators of gene expression in crucial biological processes, which converts them into high potential contenders in the ongoing search for effective therapeutic strategies. However, extracellular RNAs are unstable and rapidly degraded, reducing the possibility of successfully exerting a biological function in distant target cells. Strategies aimed at enhancing the therapeutic potential of miRNAs include the development of efficient, tissue-specific and nonimmunogenic delivery methods. Since miRNAs were discovered to be naturally transported within exosomes, a type of extracellular vesicle that confers protection against RNase degradation and increases miRNA stability have been proposed as ideal delivery vehicles for miRNA-based therapy. Although research in this field has grown rapidly in the last few years, a standard, reproducible and cost-effective protocol for exosome isolation and extracellular RNA delivery is lacking. We aimed to evaluate the use of milk-derived extracellular vesicles as vehicles for extracellular RNA drug delivery. With this purpose, exosomes were isolated from raw bovine milk, combining ultracentrifugation and size exclusion chromatography (SEC) methodology. Isolated exosomes were then loaded with exogenous hsa-miR148a-3p, a highly expressed miRNA in milk exosomes. The suitability of exosomes as delivery vehicles for extracellular RNAs was tested by evaluating the absorption of miR-148a-3p in hepatic (HepG2) and intestinal (Caco-2) cell lines. The potential exertion of a biological effect by miR-148a-3p was assessed by gene expression analysis, using microarrays. Results support that bovine milk is a cost-effective source of exosomes which can be used as nanocarriers of functional miRNAs with a potential use in RNA-based therapy. In addition, we show here that a combination of ultracentrifugation and SEC technics improve exosome enrichment, purity, and integrity for subsequent use. MDPI 2021-01-22 /pmc/articles/PMC7865385/ /pubmed/33499350 http://dx.doi.org/10.3390/ijms22031105 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
del Pozo-Acebo, Lorena
López de las Hazas, M-C
Tomé-Carneiro, Joao
Gil-Cabrerizo, Paula
San-Cristobal, Rodrigo
Busto, Rebeca
García-Ruiz, Almudena
Dávalos, Alberto
Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title_full Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title_fullStr Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title_full_unstemmed Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title_short Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
title_sort bovine milk-derived exosomes as a drug delivery vehicle for mirna-based therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865385/
https://www.ncbi.nlm.nih.gov/pubmed/33499350
http://dx.doi.org/10.3390/ijms22031105
work_keys_str_mv AT delpozoacebolorena bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT lopezdelashazasmc bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT tomecarneirojoao bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT gilcabrerizopaula bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT sancristobalrodrigo bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT bustorebeca bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT garciaruizalmudena bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy
AT davalosalberto bovinemilkderivedexosomesasadrugdeliveryvehicleformirnabasedtherapy